Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Miao-Xia Pu, Hong-Yan Guo, Zhe-Shan Quan, Xiaoting Li & Qing-Kun Shen. (2023) Application of the Mannich reaction in the structural modification of natural products. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Jing Wang, Hui-Juan Mu, Yu-Li Sun, Bo Yuan & Ying Wang. (2023) Use of honokiol in lung cancer therapy: a mini review of its pharmacological mechanism. Journal of Asian Natural Products Research 25:11, pages 1029-1037.
Read now
Read now
Ramy Ashry, Mahmoud Elhussiny, Hussein Abdellatif, Osama Elkashty, Hassan A. Abdel-Ghaffar, Essam T. Gaballa & Shaker A. Mousa. (2022) Genetic Interpretation of the Impacts of Honokiol and EGCG on Apoptotic and Self-Renewal Pathways in HEp-2 Human Laryngeal CD44high Cancer Stem Cells. Nutrition and Cancer 74:6, pages 2152-2173.
Read now
Read now
Chao Li, Zhaohui Deng, Guixian Zheng, Ting Xie, Xinyan Wei, Zengyu Huo & Jing Bai. (2021) Histone Deacetylase 2 Suppresses Skeletal Muscle Atrophy and Senescence via NF-κB Signaling Pathway in Cigarette Smoke-Induced Mice with Emphysema. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1661-1675.
Read now
Read now
Yu-Guo Yuan, Qiu-Ling Peng & Sangiliyandi Gurunathan. (2017) Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer. International Journal of Nanomedicine 12, pages 6503-6520.
Read now
Read now
Leiqiang Han, Tianqi Wang, Jingliang Wu, Xiaolan Yin, Hao Fang & Na Zhang. (2016) A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy. International Journal of Nanomedicine 11, pages 6003-6022.
Read now
Read now
Articles from other publishers (46)
Min Li, Huijuan Yu, Yiran Li, Xin Li, Shiqing Huang, Xiaogang Liu, Gaoqi Weng, Lei Xu, Tingjun Hou, Dong-Sheng Guo & Yi Wang. (2023) Rational design of supramolecular self-assembly sensor for living cell imaging of HDAC1 and its application in high-throughput screening. Biosensors and Bioelectronics 242, pages 115716.
Crossref
Crossref
N. Divya Rajaselvi, M. D. Jida, K. K. Ajeeshkumar, Suresh N. Nair, Preethy John, Zarina Aziz & A. R. Nisha. (2023) Antineoplastic activity of plant-derived compounds mediated through inhibition of histone deacetylase: a review. Amino Acids.
Crossref
Crossref
Caizhi Tian, Shuoqi Huang, Zihua Xu, Wenwu Liu, Deping Li, Mingyue Liu, Chengze Zhu, Limeng Wu, Xiaowen Jiang, Huaiwei Ding & Qingchun Zhao. (2022) Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects. Bioorganic & Medicinal Chemistry Letters 64, pages 128663.
Crossref
Crossref
Jianyu Liu, Minghai Tang, Tao Li, Zhengying Su, Zejiang Zhu, Caixia Dou, Yan Liu, Heying Pei, Jianhong Yang, Haoyu Ye & Lijuan Chen. (2022) Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition. Frontiers in Pharmacology 13.
Crossref
Crossref
Sheng-Mao Wu, Yee-Jee Jan, Shih-Chuan Tsai, Hung-Chuan Pan, Chin-Chang Shen, Cheng-Ning Yang, Shu-Hua Lee, Shing-Hwa Liu, Li-Wei Shen, Chien-Shan Chiu, Jack L. Arbiser, Menghsiao Meng & Meei-Ling Sheu. (2022) Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer. Cell Biology and Toxicology.
Crossref
Crossref
Shabir Ahmad Ganai, Farooq Ahmad Sheikh & Zahoor Ahmad Baba. (2020) Plant flavone Chrysin as an emerging histone deacetylase inhibitor for prosperous epigenetic‐based anticancer therapy. Phytotherapy Research 35:2, pages 823-834.
Crossref
Crossref
Sunil Kumar, Abhishek Kumar Sharma, H. Lalhlenmawia & Deepak Kumar. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
821
846
.
Yin-Gi Jang, Eul-Bee Ko & Kyung-Chul Choi. (2020) Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. The Journal of Nutritional Biochemistry 84, pages 108444.
Crossref
Crossref
Jih‐Tung Pai, Chia‐Yun Hsu, Yei‐San Hsieh, Tsung‐Yu Tsai, Kuo‐Tai Hua & Meng‐Shih Weng. (2020) Suppressing migration and invasion of H1299 lung cancer cells by honokiol through disrupting expression of an HDAC6‐mediated matrix metalloproteinase 9. Food Science & Nutrition 8:3, pages 1534-1545.
Crossref
Crossref
Chon Phin Ong, Wai Leong Lee, Yin Quan Tang & Wei Hsum Yap. (2019) Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers 12:1, pages 48.
Crossref
Crossref
Jie Zhang, Yueming Zhang, Wen Shen, Ran Fu, Zongli Ding, Yulong Zhen & Yufeng Wan. (2019) Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Biomedicine & Pharmacotherapy 117, pages 109058.
Crossref
Crossref
Quankun Zhuang, Ruili Pan, Xuemei Liu, Wen Xu, Hanping Wang, Xiaotong Zhang, Xintian Lai, Hongyun Wang, Li Zhang & Ji Jiang. (2019) A validated ultra-HPLC–MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study. Bioanalysis 11:11, pages 1085-1098.
Crossref
Crossref
Kishore Banik, Abhishek Manoj Ranaware, Vishwas Deshpande, Savita Pravin Nalawade, Ganesan Padmavathi, Devivasha Bordoloi, Bethsebie Lalduhsaki Sailo, Muthu K. Shanmugam, Lu Fan, Frank Arfuso, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2019) Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 144, pages 192-209.
Crossref
Crossref
Omchit Surien, Ahmad Rohi Ghazali & Siti Fathiah Masre. (2019) Lung Cancers and the Roles of Natural Compounds as Potential Chemotherapeutic and Chemopreventive Agents. Biomedical and Pharmacology Journal 12:1, pages 85-98.
Crossref
Crossref
Jianfei Zhu, Shuonan Xu, Wenli Gao, Jianyu Feng & Guolong Zhao. (2019) Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. Life Sciences 221, pages 204-211.
Crossref
Crossref
Mengyuan Cen, Yinan Yao, Luyun Cui, Guangdie Yang, Guohua Lu, Liangjie Fang, Zhang Bao & Jianying Zhou. (2018) Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop. Cancer Medicine 7:12, pages 6205-6218.
Crossref
Crossref
Huan Tang, Yongguang Zhang, Dan Li, Suhong Fu, Minghai Tang, Li Wan, Kai Chen, Zhuowei Liu, Linlin Xue, Aihua Peng, Haoyu Ye & Lijuan Chen. (2018) Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer. European Journal of Medicinal Chemistry 156, pages 190-205.
Crossref
Crossref
Zhuming Lu, Minghui Wang, Shuoyun Wu, Min Ye, Zhichao Lin, Tao Shun & Chuxiao Duan. (2018) MicroRNA‑137‑regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Wen TianYong-sheng LiJing-hua ZhangJi-jun LiJing-hua Gao. (2018)
Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified
MMP9
and
TWIST1
as Important Pathogenic Genes of Lung Adenocarcinoma
. DNA and Cell Biology 37:4, pages 336-346.
Crossref
Crossref
Kao-Jean Huang, Chin-Ho Kuo, Shu-Hsin Chen, Ching-Yen Lin & Ying-Ray Lee. (2018)
Honokiol inhibits
in vitro
and
in vivo
growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy
. Journal of Cellular and Molecular Medicine 22:3, pages 1894-1908.
Crossref
Crossref
Sahar Bayat, Mahmoud Shekari Khaniani, Jalal Choupani, Mohammad Reza Alivand & Sima Mansoori Derakhshan. (2018) HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications. Biomedicine & Pharmacotherapy 97, pages 1445-1453.
Crossref
Crossref
Jianhong Yang, Wenshuang Wu, Jiaolin Wen, Haoyu Ye, Hong Luo, Peng Bai, Minghai Tang, Fang Wang, Li Zheng, Shengyong Yang, Weimin Li, Aihua Peng, Li Yang, Li Wan & Lijuan Chen. (2017) Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells. Biomaterials 141, pages 188-198.
Crossref
Crossref
Harish C. Pal, Ram Prasad & Santosh K. Katiyar. (2017) Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1. Scientific Reports 7:1.
Crossref
Crossref
Chandraiah Godugu, Ravi Doddapaneni & Mandip Singh. (2017) Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids and Surfaces B: Biointerfaces 153, pages 208-219.
Crossref
Crossref
Bin Zhou, Haiying Li, Chongyun Xing, Haige Ye, Jianhua Feng, Jianbo Wu, Zhongqiu Lu, Jing Fang & Shenmeng Gao. (2017) Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia. Biochemical Pharmacology 128, pages 12-25.
Crossref
Crossref
A. S. Prakasha Gowda, Zucai Suo & Thomas E. Spratt. (2017) Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells. Chemical Research in Toxicology 30:2, pages 715-725.
Crossref
Crossref
Shang-Ying Wu, Yung-Shin Sun, Kuan-Chen Cheng & Kai-Yin Lo. (2017) A Wound-Healing Assay Based on Ultraviolet Light Ablation. SLAS Technology 22:1, pages 36-43.
Crossref
Crossref
Chieh-Hsiang Lu, Shu-Hsin Chen, Yi-Sheng Chang, Yi-Wen Liu, Jin-Yi Wu, Yun-Ping Lim, Hui-I Yu & Ying-Ray Lee. (2017) Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Pharmacological Research 115, pages 288-298.
Crossref
Crossref
Santosh Katiyar. (2016) Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer. Molecules 21:12, pages 1610.
Crossref
Crossref
Jung Min Song, Arunkumar Anandharaj, Pramod Upadhyaya, Ameya R. Kirtane, Jong-Hyuk Kim, Kwon Ho Hong, Jayanth Panyam & Fekadu Kassie. (2016) Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 7:36, pages 57752-57769.
Crossref
Crossref
Yuting Liu, Yunli Tong, Xia Yang, Fangyuan Li, Liang Zheng, Wenqin Liu, Jinjun Wu, Rilan Ou, Guiyu Zhang, Ming Hu, Zhongqiu Liu & Linlin Lu. (2016) Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer. Pharmacological Research 111, pages 113-125.
Crossref
Crossref
Jing Pan, Yongik Lee, Yian Wang & Ming You. (2016) Honokiol targets mitochondria to halt cancer progression and metastasis. Molecular Nutrition & Food Research 60:6, pages 1383-1395.
Crossref
Crossref
Ram Prasad, John C. Kappes & Santosh K. Katiyar. (2016) Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells. Oncotarget 7:7, pages 7899-7912.
Crossref
Crossref
Kai-Yin Lo, Shang-Ying Wu & Yung-Shin Sun. (2016) A microfluidic device for studying the production of reactive oxygen species and the migration in lung cancer cells under single or coexisting chemical/electrical stimulation. Microfluidics and Nanofluidics 20:1.
Crossref
Crossref
Yuxia Zhang, Tong Chen, Pei Yuan, Rui Tian, Wenjing Hu, Yalan Tang, Yuntao Jia & Liangke Zhang. (2015) Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydrate Polymers 133, pages 31-38.
Crossref
Crossref
Alice Pasini, Angelo Delmonte, Anna Tesei, Daniele Calistri & Emanuele Giordano. (2015) Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results. Drugs 75:15, pages 1757-1771.
Crossref
Crossref
Tripti Singh, Nirzari A. Gupta, Su Xu, Ram Prasad, Sadanandan E. Velu & Santosh K. Katiyar. (2015) Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor. Oncotarget 6:25, pages 21268-21282.
Crossref
Crossref
Jih-Tung Pai, Chia-Yun Hsu, Kuo-Tai Hua, Sheng-Yung Yu, Chung-Yang Huang, Chia-Nan Chen, Chiung-Ho Liao & Meng-Shih Weng. (2015) NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells. Molecules 20:5, pages 8000-8019.
Crossref
Crossref
Shiuan-Fu Liou, Kuo-Tai Hua, Chia-Yun Hsu & Meng-Shih Weng. (2015) Honokiol from Magnolia spp. induces G1 arrest via disruption of EGFR stability through repressing HDAC6 deacetylated Hsp90 function in lung cancer cells. Journal of Functional Foods 15, pages 84-96.
Crossref
Crossref
Jing Pan, Qi Zhang, Qian Liu, Steven M. Komas, Balaraman Kalyanaraman, Ronald A. Lubet, Yian Wang & Ming You. (2014) Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function. Cancer Prevention Research 7:11, pages 1149-1159.
Crossref
Crossref
Mohamed Saeed, Victor Kuete, Onat Kadioglu, Jonas Börtzler, Hassan Khalid, Henry Johannes Greten & Thomas Efferth. (2014) Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 21:12, pages 1525-1533.
Crossref
Crossref
Donna M. Raditic & Joseph W. Bartges. (2014) Evidence-based Integrative Medicine in Clinical Veterinary Oncology. Veterinary Clinics of North America: Small Animal Practice 44:5, pages 831-853.
Crossref
Crossref
Marisol Resendiz, Stephen Mason, Chiao-Ling Lo & Feng C. Zhou. (2014) Epigenetic regulation of the neural transcriptome and alcohol interference during development. Frontiers in Genetics 5.
Crossref
Crossref
Weidong Li, Qian Wang, Qiaozhen Su, Dandan Ma, Chang An, Lei Ma & Hongfeng Liang. (2014) Honokiol Suppresses Renal Cancer Cells? Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling. Molecules and Cells 37:5, pages 383-388.
Crossref
Crossref
Dimiter B. Avtanski, Arumugam Nagalingam, Michael Y. Bonner, Jack L. Arbiser, Neeraj K. Saxena & Dipali Sharma. (2014) Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Molecular Oncology 8:3, pages 565-580.
Crossref
Crossref
Chi-qi Chen, Cheng-shui Chen, Jun-jie Chen, Lian-ping Zhou, Hong-lei Xu, Wei-wei Jin, Jian-bo Wu & Shen-meng Gao. (2013) Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. Molecular and Cellular Biochemistry 383:1-2, pages 137-148.
Crossref
Crossref